51077-01-1,MFCD00238392
Catalog No.:AA00D8X0

51077-01-1 | 1-(Toluene-4-sulfonyl)-pyrrolidine-2-carboxylic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$62.00   $44.00
- +
5g
≥ 99% (TLC)
in stock  
$140.00   $98.00
- +
25g
≥ 99% (TLC)
in stock  
$425.00   $298.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00D8X0
Chemical Name:
1-(Toluene-4-sulfonyl)-pyrrolidine-2-carboxylic acid
CAS Number:
51077-01-1
Molecular Formula:
C12H15NO4S
Molecular Weight:
269.3168
MDL Number:
MFCD00238392
SMILES:
OC(=O)[C@@H]1CCCN1S(=O)(=O)c1ccc(cc1)C
Properties
Properties
 
Form:
Solid  
MP:
80-90℃  
Storage:
Keep in dry area;-20 ℃;  

Computed Properties
 
Complexity:
406  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.6  

Downstream Synthesis Route
98-59-9    147-85-3   
L-N-tosyl-proline 

[1]Locationinpatent:schemeortableHugenberg,Verena;Froehlich,Roland;Haufe,Guenter[OrganicandBiomolecularChemistry,2010,vol.8,#24,p.5682-5691]

[2]CurrentPatentAssignee:SINOBIOPHARMACEUTICALLIMITED;SHOUYAOHOLDINGSBEIJINGCOLTD-EP3412669,2018,A1Locationinpatent:Paragraph0208;0209

[3]CurrentPatentAssignee:WAKAMOTOPHARMACEUTICALCO.,LTD.-US6225306,2001,B1

[4]Ugwu;Okoro;Ukoha;Okafor;Ibezim;Kumar[EuropeanJournalofMedicinalChemistry,2017,vol.135,p.349-369]

[5]Ugwu,DavidIzuchukwu;Okoro,UchechukwuChris;Mishra,NarendraKumar[PLoSONE,2018,vol.13,#1]

[6]Ugwu,DavidI.;Okoro,UchechukwuC.;Mishra,NarendraK.[EuropeanJournalofMedicinalChemistry,2018,vol.154,p.110-116]

[7]Casagrande,GleisonA.;Deflon,VictorM.;Martins,GabrielR.;Oliveira-Silva,Diogo;Perecim,GivagoP.;Pinto,LeandroM.C.;Raminelli,Cristiano[Tetrahedron,2020]

[8]Han,Zhi-Jian;Wang,Rui;Zhou,Yi-Feng;Liu,Lei[EuropeanJournalofOrganicChemistry,2005,#5,p.934-938]

[9]Porchezhiyan;Kalaivani;Shobana;Noorjahan[JournalofMolecularStructure,2020,vol.1206]

[10]Porchezhiyan;Kalaivani;Shobana;Noorjahan[AsianJournalofChemistry,2020,vol.32,#4,p.853-864]

[11]Michelet,Bastien;Castelli,Ugo;Appert,Emeline;Boucher,Maude;Vitse,Kassandra;Marrot,Jérôme;Guillard,Jérôme;Martin-Mingot,Agnès;Thibaudeau,Sébastien[OrganicLetters,2020,vol.22,#13,p.4944-4948]

[12]Skowerski,Krzysztof;Pastva,Jakub;Czarnocki,StefanJ.;Janoscova,Jana[OrganicProcessResearchandDevelopment,2015,vol.19,#7,p.872-877]

[13]Szczepaniak,Grzegorz;Urbaniak,Katarzyna;Wierzbicka,Celina;Kosiński,Krzysztof;Skowerski,Krzysztof;Grela,Karol[ChemSusChem,2015,vol.8,#24,p.4139-4148]

[14]Li,Ting-Ting;Liu,Gong-Qing;Wang,Yu-Mei;Cui,Bin;Sun,Hui;Li,Yue-Ming[Tetrahedron,2015,vol.71,#38,p.7003-7009]

[15]Locationinpatent:experimentalpartDoyle,MichaelP.;Shabashov,Dmitry;Zhou,Lei;Zavalij,PeterY.;Welch,Christopher;Pirzada,Zainab[Organometallics,2011,vol.30,#13,p.3619-3627]

[16]Battisti,UmbertoM.;Corrado,Sandra;Sorbi,Claudia;Cornia,Andrea;Tait,Annalisa;Malfacini,Davide;Cerlesi,MariaCamilla;Calò,Girolamo;Brasili,Livio[MedChemComm,2014,vol.5,#7,p.973-983]

[17]Franchini,Silvia;Baraldi,Annamaria;Sorbi,Claudia;Pellati,Federica;Cichero,Elena;Battisti,UmbertoM.;Angeli,Piero;Cilia,Antonio;Brasili,Livio[MedChemComm,2015,vol.6,#4,p.677-690]

[18]Izumiya[BulletinoftheChemicalSocietyofJapan,1953,vol.26,p.53,54]

[19]Pravda;Rudinger[CollectionofCzechoslovakChemicalCommunications,1955,vol.20,p.1,7]

[20]Itoh,Takashi;Matsuya,Yûji;Enomoto,Yasuko;Ohsawa,Akio[Tetrahedron,2001,vol.57,#34,p.7277-7289]

[21]Li,Gui-Long;Zhao,Gang[OrganicLetters,2006,vol.8,#4,p.633-636]

[22]Hill,RogerR.;Moore,SharonA.;Roberts,DavidR.[PhotochemistryandPhotobiology,2005,vol.81,#6,p.1439-1446]

[23]Locationinpatent:bodytextGentilucci,Luca;Tolomelli,Alessandra;DeMarco,Rossella;Tomasini,Claudia;Feddersen,Soeren[EuropeanJournalofOrganicChemistry,2011,#25,p.4925-4930]

[24]Ugwu,DavidIzuchukwu;Okoro,UchechukwuChristopher;Ukoha,PiusOnyeoziri;Okafor,SundayN.;Gupta,Astha[JournalofEnzymeInhibitionandMedicinalChemistry,2018,vol.33,#1,p.405-415]

[25]Eze,FlorenceUchenna;Okoro,UchechukwuChris;Ugwu,DavidIzuchukwu;Okafor,SundayN.[BioorganicChemistry,2019,vol.92]

[1]Patent:US6423688,2002,B1

[1]Patent:US6583139,2003,B1

Literature

Title: Chiral organometallic triangles with Rh-Rh bonds. 2. Compounds prepared from enantiopure cis-Rh2(C6H4PPh2)2(OAc)2(HOAc)2 and their catalytic potentials.

Journal: Inorganic chemistry 20051114

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:51077-01-1 Molecular Formula|51077-01-1 MDL|51077-01-1 SMILES|51077-01-1 1-(Toluene-4-sulfonyl)-pyrrolidine-2-carboxylic acid
Catalog No.: AA00D8X0
51077-01-1,MFCD00238392
51077-01-1 | 1-(Toluene-4-sulfonyl)-pyrrolidine-2-carboxylic acid
Pack Size: 1g
Purity: 98%
in stock
$62.00 $44.00
Pack Size: 5g
Purity: ≥ 99% (TLC)
in stock
$140.00 $98.00
Pack Size: 25g
Purity: ≥ 99% (TLC)
in stock
$425.00 $298.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00D8X0
Chemical Name: 1-(Toluene-4-sulfonyl)-pyrrolidine-2-carboxylic acid
CAS Number: 51077-01-1
Molecular Formula: C12H15NO4S
Molecular Weight: 269.3168
MDL Number: MFCD00238392
SMILES: OC(=O)[C@@H]1CCCN1S(=O)(=O)c1ccc(cc1)C
Properties
Form: Solid  
MP: 80-90℃  
Storage: Keep in dry area;-20 ℃;  
Complexity: 406  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.6  
Downstream Synthesis Route
98-59-9    147-85-3   
L-N-tosyl-proline 

[1]Locationinpatent:schemeortableHugenberg,Verena;Froehlich,Roland;Haufe,Guenter[OrganicandBiomolecularChemistry,2010,vol.8,#24,p.5682-5691]

[2]CurrentPatentAssignee:SINOBIOPHARMACEUTICALLIMITED;SHOUYAOHOLDINGSBEIJINGCOLTD-EP3412669,2018,A1Locationinpatent:Paragraph0208;0209

[3]CurrentPatentAssignee:WAKAMOTOPHARMACEUTICALCO.,LTD.-US6225306,2001,B1

[4]Ugwu;Okoro;Ukoha;Okafor;Ibezim;Kumar[EuropeanJournalofMedicinalChemistry,2017,vol.135,p.349-369]

[5]Ugwu,DavidIzuchukwu;Okoro,UchechukwuChris;Mishra,NarendraKumar[PLoSONE,2018,vol.13,#1]

[6]Ugwu,DavidI.;Okoro,UchechukwuC.;Mishra,NarendraK.[EuropeanJournalofMedicinalChemistry,2018,vol.154,p.110-116]

[7]Casagrande,GleisonA.;Deflon,VictorM.;Martins,GabrielR.;Oliveira-Silva,Diogo;Perecim,GivagoP.;Pinto,LeandroM.C.;Raminelli,Cristiano[Tetrahedron,2020]

[8]Han,Zhi-Jian;Wang,Rui;Zhou,Yi-Feng;Liu,Lei[EuropeanJournalofOrganicChemistry,2005,#5,p.934-938]

[9]Porchezhiyan;Kalaivani;Shobana;Noorjahan[JournalofMolecularStructure,2020,vol.1206]

[10]Porchezhiyan;Kalaivani;Shobana;Noorjahan[AsianJournalofChemistry,2020,vol.32,#4,p.853-864]

[11]Michelet,Bastien;Castelli,Ugo;Appert,Emeline;Boucher,Maude;Vitse,Kassandra;Marrot,Jérôme;Guillard,Jérôme;Martin-Mingot,Agnès;Thibaudeau,Sébastien[OrganicLetters,2020,vol.22,#13,p.4944-4948]

[12]Skowerski,Krzysztof;Pastva,Jakub;Czarnocki,StefanJ.;Janoscova,Jana[OrganicProcessResearchandDevelopment,2015,vol.19,#7,p.872-877]

[13]Szczepaniak,Grzegorz;Urbaniak,Katarzyna;Wierzbicka,Celina;Kosiński,Krzysztof;Skowerski,Krzysztof;Grela,Karol[ChemSusChem,2015,vol.8,#24,p.4139-4148]

[14]Li,Ting-Ting;Liu,Gong-Qing;Wang,Yu-Mei;Cui,Bin;Sun,Hui;Li,Yue-Ming[Tetrahedron,2015,vol.71,#38,p.7003-7009]

[15]Locationinpatent:experimentalpartDoyle,MichaelP.;Shabashov,Dmitry;Zhou,Lei;Zavalij,PeterY.;Welch,Christopher;Pirzada,Zainab[Organometallics,2011,vol.30,#13,p.3619-3627]

[16]Battisti,UmbertoM.;Corrado,Sandra;Sorbi,Claudia;Cornia,Andrea;Tait,Annalisa;Malfacini,Davide;Cerlesi,MariaCamilla;Calò,Girolamo;Brasili,Livio[MedChemComm,2014,vol.5,#7,p.973-983]

[17]Franchini,Silvia;Baraldi,Annamaria;Sorbi,Claudia;Pellati,Federica;Cichero,Elena;Battisti,UmbertoM.;Angeli,Piero;Cilia,Antonio;Brasili,Livio[MedChemComm,2015,vol.6,#4,p.677-690]

[18]Izumiya[BulletinoftheChemicalSocietyofJapan,1953,vol.26,p.53,54]

[19]Pravda;Rudinger[CollectionofCzechoslovakChemicalCommunications,1955,vol.20,p.1,7]

[20]Itoh,Takashi;Matsuya,Yûji;Enomoto,Yasuko;Ohsawa,Akio[Tetrahedron,2001,vol.57,#34,p.7277-7289]

[21]Li,Gui-Long;Zhao,Gang[OrganicLetters,2006,vol.8,#4,p.633-636]

[22]Hill,RogerR.;Moore,SharonA.;Roberts,DavidR.[PhotochemistryandPhotobiology,2005,vol.81,#6,p.1439-1446]

[23]Locationinpatent:bodytextGentilucci,Luca;Tolomelli,Alessandra;DeMarco,Rossella;Tomasini,Claudia;Feddersen,Soeren[EuropeanJournalofOrganicChemistry,2011,#25,p.4925-4930]

[24]Ugwu,DavidIzuchukwu;Okoro,UchechukwuChristopher;Ukoha,PiusOnyeoziri;Okafor,SundayN.;Gupta,Astha[JournalofEnzymeInhibitionandMedicinalChemistry,2018,vol.33,#1,p.405-415]

[25]Eze,FlorenceUchenna;Okoro,UchechukwuChris;Ugwu,DavidIzuchukwu;Okafor,SundayN.[BioorganicChemistry,2019,vol.92]

6006-15-1    66845-42-9    51077-01-1    220176-28-3 

[1]Patent:US6423688,2002,B1

109-02-4    14173-40-1    51077-01-1    220302-57-8 

[1]Patent:US6583139,2003,B1

Literature fold

Title: Chiral organometallic triangles with Rh-Rh bonds. 2. Compounds prepared from enantiopure cis-Rh2(C6H4PPh2)2(OAc)2(HOAc)2 and their catalytic potentials.

Journal: Inorganic chemistry20051114

Building Blocks More >
56161-89-8
56161-89-8
Methyl 4-(2-amino-ethyl)-benzoate, HCl
AA00D92H | MFCD08059241
436086-92-9
436086-92-9
3-(3,5-Dimethyl-1h-pyrazol-1-yl)-2-methylpropanoic acid
AA00D98D | MFCD03444758
52708-32-4
52708-32-4
4-(3,5-Dimethyl-1H-pyrazol-1-yl)aniline
AA00D9FT | MFCD00661746
50884-94-1
50884-94-1
2-Bromo-3-fluoro-3-methylbutyric acid
AA00D9NQ | MFCD08704576
5409-15-4
5409-15-4
4-Chloro-1-hydroxynaphthalene-2-carboxylic acid
AA00D9TS | MFCD00458680
53643-14-4
53643-14-4
4-METHYLUMBELLIFERYL BETA-D-N,N',N',N''-TETRAACETYLCHITOTETRAOSIDE
AA00DA0R | MFCD00274442
51705-19-2
51705-19-2
16-PHENOXY TETRANOR PROSTAGLANDIN F2ALPHA
AA00DA6N | MFCD00135252
476004-83-8
476004-83-8
Furan-2,5-diboronic acid, pinacol ester
AA00DAA5 | MFCD11504967
438531-42-1
438531-42-1
2-(3-Aminophenyl)-6-bromoquinoline-4-carboxylic acid
AA00DAGJ | MFCD02055898
497246-54-5
497246-54-5
Methyl 3-(2-amino-4-hydroxy-6-methylpyrimidin-5-yl)propanoate
AA00DAMJ | MFCD18822106
Submit
© 2017 AA BLOCKS, INC. All rights reserved.